Diphtheria
GlaxoSmithKline's investigational DTaP-IPV combination vaccine shown to be immunogenic and well-tolerated in Phase III clinical trial
Published in MD Week, May 25th, 2007
GlaxoSmithKline (GSK) today announced results from a U.S. phase III vaccine clinical study presented this week at the Pediatric Academic Societies' (PAS) Annual Meeting in Toronto, Canada. The study evaluated the immune response and safety profile of the investigational combination DTaP-IPV (diphtheria, tetanus, acellular pertussis - inactivated poliovirus) vaccine in children ages 4 to 6 years-old as compared to separately administered DTaP (INFANRIX(R)) and IPV (IPOL(R)) vaccines, when co-administered with measles, mumps and rubella (MMR) vaccine (M-M-RII(R)) at a separate site. Study results showed that children receiving the combination vaccine demonstrated overall a comparable...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of MD Week
Source: MD Week (2007-05-25)
More Articles from MD Week
- Anatomy
Studies from University of Bristol, Department of Anatomy add new findings in the area of anatomy - Arthritis Risk Factors
New findings from Johns Hopkins Bayview Medical Center, Division of Rheumatology describe advances in arthritis risk factors - Cancer Vaccines
Stanford researchers identify immune dysfunction in melanoma patients - Depression
CMS Issues Decision for Vns Therapy In Treatment-resistant Depression - Gender Studies
University of Wolverhampton reports research in gender studies - Gynecology
A few more minutes of maternal attachment may reduce anemia in children - More from this issue of MD Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
